Non-Nuclear Wld <sup>S</sup> Determines Its Neuroprotective Efficacy for Axons and Synapses <i>In Vivo</i>
Bogdan Beirowski(The Ohio State University Wexner Medical Center), Michael P. Coleman(Babraham Institute), Lucie Janečková(Institute of Molecular Genetics), Giulio Magni(Marche Polytechnic University), Francesca Mazzola(Marche Polytechnic University), Jon Gilley(Babraham Institute), Elisabetta Babetto(The Ohio State University Wexner Medical Center), Richard R. Ribchester(University of Edinburgh), Laura Conforti(University of Cincinnati)
Cited by 98
Related Papers
Wallerian degeneration: an emerging axon death pathway linking injury and disease
|Nature reviews. Neuroscience|2014|627
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
|Nature Neuroscience|2001|616
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
|Cell Death and Differentiation|2014|263
A <i>Ufd2/D4Cole1e</i> chimeric protein and overexpression of <i>Rbp7</i> in the slow Wallerian degeneration ( <i>Wld</i> <sup>S</sup> ) mouse
|Proceedings of the National Academy of Sciences|2000|253